A Phase 1 Trial of Extended MLN8054 Dosing in Patients With Advanced Malignancies
Clinical trial NCT00652158 · TERMINATED
Trial details
- NCT number
- NCT00652158
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2008-03-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.